Ovid Therapeutics Inc.
OVID
$2.70
-$0.05-1.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.66% | -275.80% | 179.48% | -159.56% | 54.24% |
| Total Depreciation and Amortization | -54.29% | 105.88% | 6.25% | -83.84% | -29.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.07% | 103.57% | -2,204.27% | -8.91% | -5.55% |
| Change in Net Operating Assets | -255.87% | 1,640.30% | 107.92% | -35.93% | 4.53% |
| Cash from Operations | -26.58% | -33.54% | 19.14% | -169.63% | 53.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,557.82% | 108.26% | -1,526.12% | -58.08% | 136.24% |
| Cash from Investing | -1,557.82% | 108.26% | -1,526.12% | -58.08% | 136.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.33% | 15.21% | 501,093.33% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | -- | -- |
| Cash from Financing | -75.72% | 18.36% | 501,093.33% | -- | -100.00% |
| Foreign Exchange rate Adjustments | 96.72% | 26.95% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.26% | 1,184.89% | 4.43% | -207.21% | 240.93% |